1. Home
  2. VLY vs INAB Comparison

VLY vs INAB Comparison

Compare VLY & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

HOLD

Current Price

$12.27

Market Cap

6.6B

Sector

Finance

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$2.37

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLY
INAB
Founded
1927
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
10.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VLY
INAB
Price
$12.27
$2.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
2
Target Price
$13.14
$108.00
AVG Volume (30 Days)
5.9M
709.2K
Earning Date
01-23-2026
11-06-2025
Dividend Yield
3.65%
N/A
EPS Growth
40.78
N/A
EPS
0.88
N/A
Revenue
$1,704,193,000.00
N/A
Revenue This Year
$33.72
N/A
Revenue Next Year
$10.15
N/A
P/E Ratio
$13.72
N/A
Revenue Growth
8.06
N/A
52 Week Low
$7.48
$1.17
52 Week High
$12.18
$12.53

Technical Indicators

Market Signals
Indicator
VLY
INAB
Relative Strength Index (RSI) 69.53 59.09
Support Level $11.54 $2.33
Resistance Level $12.01 $2.59
Average True Range (ATR) 0.21 0.28
MACD -0.01 0.07
Stochastic Oscillator 94.74 78.32

Price Performance

Historical Comparison
VLY
INAB

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: